Abstract
Cerebrospinal fluid is a dynamic, metabolically active substance that has numerous important functions. It is considered a valuable diagnostic aid in assessing infectious inflammatory conditions, involving the brain, spinal cord, and meninges.
The discovery and use of antimicrobial agents has fundamentally changed medicine from a therapeutic point of view, enabling the treatment of many diseases once considered threatening and deadly. However, after prolonged exposure of various microorganisms to these agents, the development of antimicrobial resistance has been enabled through the adaptive selection mechanism. The emergence of this resistance in the main pathogenic microorganisms is a very problematic and threatening issue in public health, making it a global problem. Resistance of various microorganisms in Kosovo, according to annual reports of CAESAR, compared to other European countries, is quite worrying. It reaches the tops of the lists for high resistance, along with other Balkan countries, such as Serbia, Montenegro, and North Macedonia.
The purpose of this research was to define the etiology and level of resistance of microorganisms to antimicrobial agents, which are encountered in invasive samples of cerebrospinal fluid. This research is a retrospective, descriptive type analysis, which includes the data gathered from January 1, 2014 to May 7, 2019. We have a total of 185 bacteria isolated from 1499 isolates, conducted at the National Institute of Public Health in Kosovo. The determination of antimicrobial resistance was performed according to automated systems and the method of disk diffusion.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding was received for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The dataset used for this study was provided by IKSHPK Prishtina and is publicly available.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.